New Filters: Mergers and Acquisitions

If you are not happy with the results, please do another search

JSA Advises Searchspring on Strategic Acquisition of AI Search Leader Klevu, Forming Athos Commerce

JSA advised Searchspring Holdings LP, a global leader in online product discovery and a portfolio company of PSG Equity, on its acquisition of Klevu, an AI-driven search and discovery company headquartered in Finland.

The combination of Searchspring and Klevu has resulted in the formation of a new, rebranded platform called Athos Commerce.

Searchspring specializes in site search, product merchandising, and ecommerce personalization. Klevu provides search optimization services for online retailers and operates globally, including in the United Kingdom, United States, Australia, Sweden, and India.

The JSA team was led by Rohan Kumar, Partner, who helped lead the merger which strengthens the combined entity’s position as a global leader in ecommerce product discovery and AI-driven search solutions.Associate, Regan D’mello, supported Rohan Kumar..

This transaction highlights JSA’s expertise in advising on complex cross-border M&A and growth transactions within the technology and ecommerce sectors.

Tags AI in Ecommerce, Athos Commerce, Cross Border Mergers, Digital Commerce, Ecommerce Law, Global M&A, JSA, Klevu, Mergers and Acquisitions, Searchspring, Tech Mergers, Tech Transactions

Merger of Cohance Lifesciences with and into Suven Pharmaceuticals

JSA advised Advent International and Suven Pharmaceuticals Limited, which is listed in India, in the ~USD 3 billion dollar (combined) merger of Cohance Lifesciences Limited with and into Suven Pharmaceuticals Limited, as one of the largest transactions of its kind.

Following the merger, Suven Pharmaceuticals Limited has now been renamed as Cohance Lifesciences Limited.

Our transaction team was led by Partner & National Corporate Lead, Iqbal Khan & Partner, Ambarish with support from Principal Associate, Krishaal Morjaria, Senior Associate, Tarini Sardesai & Associates Ayushi Choudhary and Raviraj Zinzuvadia.

Deal value – ~USD 3 billion.

Media coverage – Business Standard

Tags Advent International, CDMO industry, Cohance Lifesciences, Corporate Law, Cross Border Transactions, Indian Pharma, JSA deal, JSA Deal Alert, Life Sciences Law, Pharma Mergers, Suven Pharma, USD 3 Billion Deal

Novopor Advanced Science, a portfolio company of Bain Capital, acquires Pressure Chemical Company

JSA advised Novopor Advanced Science Private Limited, a portfolio company of Bain Capital, on its acquisition of PressureKem Inc., the holding company of Pressure Chemical Company, a US based entity specializing in high-pressure chemistry, polymerization, alkoxylation, and challenging chemistry scale-up.

Our transaction team comprised of Lead Partner & National Corporate Lead, Iqbal Khan, Partner, Ashid Basheer, Senior Associate, Pratyush Hari and Associate, Gunjan Singh.

Our finance team comprised Partner, Soumitra Majumdar and Shrijita Bhattacharya and Principal associate, Harvi Shah.

Tags Bain Capital, Chemical Manufacturing, Corporate Law, Cross border M&A, Finance Team, International Deals, JSA deal, JSA Deal Alert, Novopor, Pressure Chemical, Scale Up Chemistry, Specialty Chemicals

Acquisition of shares of Ravula Health Care Private Limited by Unipath Specialty Laboratory

JSA advised Unipath Specialty Laboratory Limited on the acquisition of equity share capital of Ravula Health Care Private Limited, an entity engaged in providing pathology, diagnostic, and imaging services. The transaction is structured in multi-independent tranches resulting in acquisition of 100% shares of Ravula Health Care Private Limited by Unipath Specialty Laboratory Limited. Unipath Specialty Laboratory Limited has successfully established itself as one of the leading diagnostic brands in Western India having successfully expanded across 11 states.

Our deal team comprised Partner, Rinku Ambekar and Principal Associate, Reshma Oak.

Tags Corporate Law, Diagnostics Sector, Equity Acquisition, Healthcare Deals, Imaging Services, JSA deal, JSA Deal Alert, Mergers and Acquisitions, Private Equity, Transaction Advisory

JSA advised Unipath Specialty Laboratory Limited on the Joint Venture with Dr. Sanjay Jayantilal Mehta

JSA advised Unipath Specialty Laboratory Limited on the Joint Venture with Dr. Sanjay Jayantilal Mehta wherein Unipath acquired initial 51% equity share capital and 100% of redeemable convertible preference shares of Dr. Sanjay Mehta Unipath Speciality Laboratory Private Limited, an entity engaged in providing render pathology and radiology services. The transaction is structured in multi-independent tranches resulting in acquisition of 100% equity shares of Dr. Sanjay Mehta Unipath Speciality Laboratory Private Limited by Unipath Specialty Laboratory Limited. Unipath Specialty Laboratory Limited has successfully established itself as one of the leading diagnostic brands in Western India having successfully expanded across 11 states.

Our deal team comprised Partner, Rinku Ambekar and Principal Associate, Reshma Oak.

Tags Corporate Law, Diagnostics Sector, Healthcare Deals, India Healthcare, Joint Venture, JSA deal, JSA Deal Alert, Mergers and Acquisitions, Private Equity, Transaction Advisory

Serum Institute of India sells 35% shareholding in Schott Poonawala to TPG

JSA advised Serum Institute of India Private Limited (“Serum”), in its sale of 35% stake in Schott Poonawalla Private Limited (“Schott Poonawalla”) to TPG Scion Unit Trust (acting through its trustee Scion Trustee Limited) (“TPG”). Schott Poonawalla is a joint venture between Serum and the Schott group – pursuant to the proposed sale, the Schott group remains a majority shareholder in Schott Poonawalla, while Serum and TPG will hold 15.01% and 34.99%, respectively. The transaction was subject to CCI approval, which was successfully received last month. JSA was assisted by Gibson, Dunn & Crutcher LLP on the anti-bribery and anti-corruption-related aspects of the transaction.

SCHOTT Poonawalla is India’s largest injectables-focused drug containment solutions company, offering a comprehensive product portfolio of the highest quality for over two decades.

Our transaction team comprised Lead Partner & National Corporate Lead, Iqbal Khan, Partner, Devika Menon, Senior Associate, Subbalaxmi S and Associate, Gunjan Singh.

Our competition team comprised Partner and Chair, Competition Law, Nisha Kaur Uberoi, Principal Associate, Rahat Dhawan, Senior Associate, Rishi Kauntia and Associate, Cherian Chacko Manayath.

Media coverage – Business Standard

Tags CCI Approval, Cross border transaction, Drug Containment Solutions, India Deals, Injectables, Joint Venture, JSA Deal Alert, Legal Advisory, Pharma Packaging, Private Equity, Stake sale, Strategic Investment

JSA advised Nittoseiko Co., Ltd. on its 100% acquisition of shares in Vulcan Forge Private Limited

JSA advised Nittoseiko Co., Ltd. (“NS”), a publicly listed Japanese company engaged in the development and manufacture of products using fastening, assembly, and inspection technologies, on its 100% acquisition of Vulcan Forge Private Limited (“VF”). Upon completion of the transaction, VF and its wholly owned subsidiary, Vulcan Cold Forge Private Limited (“VCForge”) became the subsidiaries of NS. JSA team was involved in conducting comprehensive legal due diligence on VF and VCForge, as well as advising on transaction structuring and regulatory aspects, including matters relating to foreign direct investment.

Our transaction team comprised of Lead Partner, Trisheet Chatterjee, Partner, Sarvesh Kumar Saluja, Senior Associates, Kaishori Raut and Neeral Jain & Associates, Purboday Patitunda and Sourish Bagchi.

Tags Business Expansion, Corporate Law, Cross Border Deals, Fdi, Foreign Direct Investment, Japan India, JSA, JSA deal, JSA Deal Alert, Legal Due Diligence, Mergers and Acquisitions, Strategic Acquisition, Transaction Advisory

ITC Limited to raise its stake in Mother Sparsh, and undertake full acquisition in 2-3 years

JSA is advising Mother Sparsh Baby Care Private Limited (Mother Sparsh) in relation to its proposed acquisition by ITC Limited. ITC Limited is an existing shareholder of Mother Sparsh and currently holds 26.5% of its share capital. ITC Limited will now invest INR 81 crore to raise its stake in Mother Sparsh to 49.3%, with a target to undertake full acquisition of Mother Sparsh, in multiple tranches, over a time period of about 2-3 years. The 100% acquisition will be made through a combination of primary subscription and secondary share purchase. Mother Sparsh is a premium ayurvedic and natural personal care start-up, which is focused on baby personal care, health & hygiene and expert baby care.

Our transaction team comprised of Lead Partner, Sidharrth Shankar, Partner, Prakriti Jaiswal, Principal Associate, Anindita Basu and Senior Associate, Rishika Agarwal.

Tags Ayurveda, Corporate Law, Deal Announcement, ITC, JSA, JSA Deal Alert, Mergers and Acquisitions, Mother Sparsh, Personal Care, Private Equity, Startups

JSA Advises ELIQUENT Life Sciences and GHO Capital on its acquisition of 100% stake in Truliant Consulting

JSA advised ELIQUENT Life Sciences and GHO Capital on its 100% acquisition of Truliant Consulting Private Limited, as part of the global acquisition of its group company, Truliant Consulting LLC. ELIQUENT Life Sciences is a leading global consulting group delivering regulatory affairs, pharmacovigilance, quality and compliance solutions that support clients across therapeutic modalities, phase-based pathways and major global markets.

The integration of Truliant’s specialized knowledge and technology-driven service offerings expands ELIQUENT’s pharmacovigilance platform.

JSA assisted in all aspects of the transaction at the India level including structuring, negotiating, drafting and finalizing the definitive agreements.

The transaction team comprised of Lead Partner, Anand Lakra, Partner, Niharika Mepani, Principal Associate, Ami Shah, Associates, Rishabh Sharma, Diya Daveand Ishan Saxena.

Our employment team comprised of Partner, Sonakshi Das and Associate, Ananya Sharma.

Our taxation team comprised of Partner and Head of Practice, Direct Tax Kumarmanglam Vijay, Partner, Surajkumar Shetty and Associate, Tejasvi Shukla.

Media Coverage – Businesswire

Tags Compliance solutions, Corporate Law, Cross border deal, Deal advisory, ELIQUENT Life Sciences, GHO capital, Global integration, Healthcare industry, India M&A, JSA, JSA deal, JSA Deal Alert, Life Sciences, Mergers and Acquisitions, Pharma consulting, Pharmacovigilance, Quality management, Regulatory affairs, Truliant Consulting

1 Crowd Series A Investment in Gostops Hospitality

JSA represented 1Crowd in its primary investment in Gostops Hospitality Private Limited. In addition to 1Crowd the Series A round secured investment from Blume (lead investor) and other existing investors.

The team assisted in all aspects of the transaction, including structuring, negotiating and finalising the definitive agreements. Gostops Hospitality offers vibrant, social, and design-led hostel spaces for the new generation primarily in India. The funding will be used to strengthen operations, enhance technology, and elevate the social and experiential aspects of its existing properties, reinforcing goSTOPS as the preferred travel and lifestyle brand for India’s youth.

The transaction was led by Lead Partner, Kanishka Bajpai and Associate, Rahi Barfiwala.

Media Coverage – CNBC TV18 .